Novavax says its coronavirus vaccine produced immune response in small study

Novavax Inc said on Tuesday its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to initial data from a small, early-stage clinical trial.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *